Title : Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.

Pub. Date : 2015 Dec

PMID : 25307746






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pioglitazone, a PPARgamma agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling. Pioglitazone advanced glycosylation end-product specific receptor Homo sapiens
2 We hypothesized that the pathological receptor for advanced glycation end products (RAGE) is involved in the PGZ anti-tumor process. Pioglitazone advanced glycosylation end-product specific receptor Homo sapiens
3 We hypothesized that the pathological receptor for advanced glycation end products (RAGE) is involved in the PGZ anti-tumor process. Pioglitazone advanced glycosylation end-product specific receptor Homo sapiens
4 Moreover, PGZ inhibited proliferative activity and invasive potential, and induced apoptosis and cell cycle arrest in HCC cells resulting in increased expression of PPARgamma and decreased expression of RAGE, NF-kappaB, HMGB1, p38MAPK, Ki-67, MMP-2, and CyclinD1. Pioglitazone advanced glycosylation end-product specific receptor Homo sapiens
5 Furthermore, knockdown of RAGE or NF-kappaB by siRNA effectively suppressed cell proliferation and invasion, and mediated the inhibitory effects of PGZ in HCC cells. Pioglitazone advanced glycosylation end-product specific receptor Homo sapiens
6 In addition, PGZ as a PPARgamma agonist may inhibit growth and invasion of HCC cells via blockade of the RAGE signaling. Pioglitazone advanced glycosylation end-product specific receptor Homo sapiens